|Previous Section||Index||Home Page|
Ms Rosie Winterton: It is the responsibility of national health service trusts to assess the effect on patient safety of temporary nursing in the NHS. Staff provided by NHS Professionals, are subject to the same stringent checks as any other substantive employee and as set out in the NHS Employers' document "Safer RecruitmentA Guide for NHS Employers. In addition, nursing agencies, on the NHS Purchasing and Supply Agency Framework Agreements, are audited on an annual basis.
Ms Rosie Winterton: It is the responsibility of national health service trusts to plan and manage their demand for temporary nursing staff in the context of local business and workforce planning. NHS Professionals can play a significant role in assisting trusts manage their demand whilst maintaining quality and achieving value for money.
Mr. Stephen O'Brien: To ask the Secretary of State for Health what assessment she has made of whether emergency medical technicians are able to deliver the same level of care as paramedics in the case of callouts to patients with epilepsy and cerebral palsy. 
Andy Burnham: The treatment administered to a patient with cerebral palsy would depend on the primary illness, symptoms or injury that they presented with rather than necessarily the underlying condition. I refer the hon. Member to the answer I gave him on 6 June 2007, Official Report, column 559W, in which I provided information on the types of care that can be provided by an ambulance paramedic and an emergency medical technician (EMTs). In relation specifically to the treatment of patients with epilepsy, paramedics can supply and administer rectal diazepam, whilst EMTs can only administer the drug if it was already in the possession of the patient.
Mr. Watson: To ask the Secretary of State for Health which NHS ambulance trusts issue their paramedics with stab proof vest protection; what discussion she has held on stab proof vest protection for paramedics; what assessment she has made of the merits of providing stab proof vest protection for paramedics; and if she will make a statement. 
Ms Rosie Winterton: In April 2003, the NHS Security Management Service (NHS SMS) was created and assumed responsibility for the management of security related matters in the national health service, including tackling violence against NHS staff.
However, information on the NHS ambulance trusts which issue their paramedics with stab proof vest protection is not held centrally. Each trust will make their own decision based on local risk assessments.
|Emergency calls and emergency incidents (calls resulting in response arriving at the scene of the incident) by specified ambulance service( 1) , 2002-03 to 2006-07|
|n/a = not applicable.|
(1) On 1 July 2006, Sussex ambulance service merged with Surrey ambulance service and Kent ambulance service to become South East Coast Ambulance Service Trust. Data is only available for ambulance trusts, it is not available for the location of the incident.
Information Centre for Health and Social Care
Caroline Flint: In 2006, 10.769 million prescription items were dispensed for benzodiazepines in the community in England. Benzodiazepines are defined in section 4.1.1 and 4.1.2 of the British National Formulary (BNF). Benzodiazepines defined in section 4.8.1 of the BNF for the treatment of epilepsy are not included.
Jenny Willott: To ask the Secretary of State for Health pursuant to the answer of 12 June 2007, Official Report, column 988W, on blood: contamination, what correspondence her Department has had with (a) the UK Haemophilia Centre Doctors Organisation and (b) clinicians on the inquiry chaired by Lord Archer into contaminated blood and blood products; and if she will make a statement. 
Jenny Willott: To ask the Secretary of State for Health pursuant to the answer of 4 June 2007, Official Report, columns 279-80W, on blood: imports, (1) how much was spent on commercially imported AHG concentrate/factor VIII blood products by health authorities under arrangements centrally negotiated by her Department in each year from 1977 to 1990; and if she will make a statement; 
(2) what records her Department holds on centrally negotiated arrangements for the purchase of commercially imported AHG concentrate/factor VIII blood products for health authorities in the 1970s and 1980s; and if she will make a statement; 
Jenny Willott: To ask the Secretary of State for Health pursuant to the answer of 15 June 2007, Official Report, column 1381W, on blood: safety, on what date her Department plans to release the next batch of documents identified in the Review of Documentation relating to the safety of Blood Products 1970 to 1985; and if she will make a statement. 
Caroline Flint: The first batch of papers were sent to the inquiry team on 15 June. Arrangements are in hand to place these papers on the Department's website. As indicated previously we will be sending papers to the inquiry team at monthly intervals.
Mr. Greg Knight: To ask the Secretary of State for Health what assessment she has made of the potential effects on the health of (a) adults and (b) children of radio waves from home wireless broadband systems; and if she will make a statement. 
Caroline Flint: The independent Advisory Group on Non-ionising Radiation (AGNIR) undertook a comprehensive assessment of radio waves and health in 2003. Its report, entitled Health Effects from Radiofrequency Electromagnetic Fields, was published by the then National Radiological Protection Board (now the Radiation Protection Division of the Health Protection Agency (HPA)). Copies are available in the Library and on the HPA website:
All devices that emit radio waves (such as wireless internet) should be used in compliance with the exposure guidelines published by the International Commission on Non-ionising Radiation Protection (ICNIRP) as specified in the European Recommendation on limiting public exposure to electromagnetic fields (EC/519/1999).
There is no consistent evidence to date that WiFi and wireless local area networks adversely affect the health of the general population. The signals are very low power, typically 0.1 watt (100 milliwatts) in both the computer and the router (access point) and the results so far show exposures are well within internationally accepted (ICNIRP) guidelines. Based on current knowledge and experience, radio frequency (RF) exposures from WiFi are likely to be lower than those from mobile phones. Also, the frequencies used in WiFi are broadly the same as those from traditional RF applications.
Mr. Amess: To ask the Secretary of State for Health what assessment she has made of the impact of (a) existing NHS deficits on the take up of treatment approved by the National Institute for Health and Clinical Excellence for use in lymphatic cancer and (b) (i) payment by results and (ii) practice based commissioning on the availability of these treatments. 
Andy Burnham: It is the responsibility of primary care trusts (PCTs) and strategic health authorities to analyse their local situation and develop plans, in liaison with their local national health service trusts and primary care providers, to deliver high quality NHS services.
PCTs are under a legal requirement to fund the provision of treatments within three months of a positive National Institute for Health and Clinical Excellence (NICE) appraisal being finalised. PCTs should use their best endeavours to ensure that any new treatments recommended by NICE are available as soon as possible after publication of final guidance. If it is possible for PCTs to make the necessary arrangements without using the full three month period then they should do so.
Where treatments and services fall under payment by results, this activity is paid for at the national tariff price. Funding for services outside the scope of payment by results is agreed locally between commissioners and providers. Under payment by results any cost implications of NICE guidance for the NHS are taken account of in two main ways:
Through an adjustment within the national tariff uplift (dealing with pay and prices, pay reform and technical issues); and
Through adjustments to specific national tariff prices where appropriate.
Practice based commissioning (PBC) gives practices and primary care professionals the freedom to develop innovative, high-quality services for their patients. It enables them, working across boundaries with secondary care clinicians and others, to redesign services that better meet the needs of their patients. By giving practices the ability to develop new services for patients within a framework of accountability and support, PBC will improve access, extend patient choice and help restore financial balance.
|Next Section||Index||Home Page|